The global gouty arthritis market is expected to witness significant growth during the forecast period. The growing acceptance of enhanced R&D on regeneration therapies, and rising incidence are the major drivers driving the gout therapeutics market. It typically affects men more than women and further damage to joints can be avoided by treatment. COVID-19 also had a major impact on the population and market growth.
Frequently Asked Questions
The market is segmented based on Segmentation, By Diagnosis (Joint Fluid Test, Blood Test, X-Ray Imaging, Ultrasound, Dual Energy CT Scan, Others), Treatment (NSAIDs, Pain Reliever, Corticosteroids, Xanthine Oxidase Inhibitors, Uricosurics, Others), Route of Administration (Oral, Parenteral, Topical, Others), End-Users (Hospitals, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others) – Industry Trends and Forecast to 2032
.
The Global Gouty Arthritis Market size was valued at USD 3.62 USD Billion in 2024.
The Global Gouty Arthritis Market is projected to grow at a CAGR of 6.5% during the forecast period of 2025 to 2032.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
